IBSA Pharma added three new dosage strengths of Tirosint® (levothyroxine sodium) capsules to treat hypothyroidism. The three new dosing options – 37.5, 44 and 62.5 micrograms – expand Tirosint's existing 12 options.
Recently published research has demonstrated that dissatisfaction is common among adults treated for hypothyroidism. While the causes of patient dissatisfaction are complex, the common practice of frequent dose titration of thyroid hormone treatment (more than two dose changes per year) has been associated with significantly lower levels of patient satisfaction with hypothyroidism therapy.